Evidence map›Paper›PMID 21805270›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2011

Creating a "hopeful monster": mouse forward genetic screens.

Vanessa L Horner, Tamara Caspary

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. eLife · 2018
    Article
  6. Article
  7. After GWAS: mice to the rescue?Current opinion in immunology · 2012
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vanessa L HornerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA. vlhorne@emory.edu
Tamara Caspary

Funding

Genetic analysis of cell fate specification in the mammalian dorsal spinal cord.F32HD060368 · NICHD · EMORY UNIVERSITY · PI HORNER, VANESSA LYNN · 2010 to 2010
$26k
NICHD NIH HHS F32 HD060368
6 · The paper itself

Abstract

One of the most straightforward approaches to making novel biological discoveries is the forward genetic screen. The time is ripe for forward genetic screens in the mouse since the mouse genome is sequenced, but the function of many of the genes remains unknown. Today, with careful planning, such screens are within the reach of even small individual labs. In this chapter we first discuss the types of screens in existence, as well as how to design a screen to recover mutations that are relevant to the interests of a lab. We then describe how to create mutations using the chemical N-ethyl-N-nitrosourea (ENU), including a detailed injection protocol. Next, we outline breeding schemes to establish mutant lines for each type of screen. Finally, we explain how to map mutations using recombination and how to ensure that a particular mutation causes a phenotype. Our goal is to make forward genetics in the mouse accessible to any lab with the desire to do it.

Indexed as

AllelesAnimalsBreedingCell LineEthylnitrosoureaFemaleFertilityGenes, DominantGenes, RecessiveGenetic TestingGenomicsHomozygoteInjectionsMaleMiceMutagenesisEthylnitrosourea

Identifiers

PMID21805270
PMCPMC3827720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.